Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
Sibei Tao(Sichuan University), Ping Fu(Shandong Center for Disease Control and Prevention), Liang Ma(Guangdong Pharmaceutical University), Min Shi(Nanfang Hospital), Qian Ren(Hebei Medical University), Zhuo Huang(Sichuan University), Xiaoxi Zeng(West China Medical Center of Sichuan University), Zijing Xia(Sichuan University), Jing Jiang(Sichuan University), Peiyun Li(University of Nottingham Ningbo China), Huichao Ma(Sichuan University), Yan Wang(St David's Medical Center), Ling Li(Sichuan University), Tian Lan(Fuzhou University), Yuan Liu(Xuzhou Medical College), Jing Liu(China Pharmaceutical University), Lingzhi Li(Affiliated Hospital of Southwest Medical University), Jing Pan(Southern Medical University), Huairong Tang(Sichuan University), Xi Tang(Sichuan University), Tiantian Wei(Sichuan University)
Cited by 183
Related Papers
Kidney fibrosis: from mechanisms to therapeutic medicines
|Signal Transduction and Targeted Therapy|2023|646
Outcomes and complications of catheter ablation for atrial fibrillation in females
|Heart Rhythm|2009|274
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
|PLoS ONE|2015|206
BATMAN-TCM 2.0: an enhanced integrative database for known and predicted interactions between traditional Chinese medicine ingredients and target proteins
|Nucleic Acids Research|2023|176
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
|Cell Metabolism|2020|171